MJ News and Press, ETFMG Alternative Harvest From 09/16/21

AdvisorShares launched the AdvisorShares Psychedelic ETF (NYSEARCA:PSIL) on Thursday, aiming to take advantage of the emerging psychedelic drug industry. The thematic fund will expose market participants to unique biotechnology, pharmaceutical, and life sciences businesses that look to captur...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips The bull market on Wall Street has been going on for at least eight years. Late last week equities hit a small snag, and sellers stepped in early everyday and ruined a perfectly strong open. Even before Wednesday’s p...

One of the most interesting things about these stocks is that, due to the fact that they don’t trade on a major U.S. exchange, many investors can’t or simply won’t buy them. As such, it may now finally be time to get bullish on green bud. The stocks have been abso...

RIV Capital, formerly known as Canopy Rivers, is an investment and acquisition company in the cannabis industry. CEO Narbé Alexandrian joins us to discuss moving on from Canopy Growth and why it views the US as the holy grail of cannabis. Strategic investment from Scotts Mira...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Pot stocks look terrible, and you should stay far away until something major changes. Today we’re analyzing the space through the lens of Canopy Growth (NYSE: CGC ) stock, but you can substitute its chart with ...

180 Life Sciences' Prof. Sir Marc Feldmann, who co-founded ATNF with cannabis trailblazer Prof. Raphael Mechoulam, joins the podcast with Dr. Jonathan Rothbard, Chief Science Officer. Focusing on pain and inflammation space. Aiming for FDA approval. Human clinical trials. Limitati...

InterCure is the most profitable cannabis company outside North America and recently uplisted to Nasdaq. Israel's former Prime Minister, Chairman Ehud Barak and CEO Alex Rabinovitch join the podcast to discuss Israel's cannabis landscape and what investors can expect going forward. ...

Top Cannabis ETFs In Q4 2021 Are you looking for ways to invest in the cannabis industry in 2021? For the past several months many leading cannabis stocks have experienced a pullback that has left the cannabis sector trading at some of its lowest market value this year. Although lea...

180 Life Sciences' Prof. Sir Marc Feldmann, who co-founded ATNF with cannabis trailblazer Prof. Raphael Mechoulam, joins the podcast with Dr. Jonathan Rothbard, Chief Science Officer. Focusing on pain and inflammation space. Aiming for FDA approval. Human clinical trials. Limitati...

Tim Seymour returns to the podcast to discuss cannabis investors getting more sophisticated as the industry grows up. Holding management teams more accountable, multiple quarters of execution, profitability as a relative term. Macro picture is both tremendously promising and frust...